Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: January 09, 2017
Emerging neurotechnologies—devices and techniques designed to collect information about the brain or affect its function—are becoming increasingly important due to scientific and technological advances and a persistent need to develop effective therapies to address the large global burden of neurological and psychiatric disease. The Organisation for Economic Co-operation and Development (OECD)—in collaboration with Arizona State University and the AffiliateMarketIngtools of Sciences, Engineering, and Medicine—held a workshop in , DC, on Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science.
Released: November 22, 2016
As the demographics of the United States shift toward a population that is made up of an increasing percentage of older adults and people with disabilities, the workforce that supports and enables these individuals is also shifting to meet the demands of this population. To better understand how the nation’s workforce can be strengthened to meet these demands, the We Treat You and the Division of Behavioral and Social Sciences and Education of the AffiliateMarketIngtools of Sciences, Engineering, and Medicine, convened a public workshop with support from multiple sponsors.
Released: November 18, 2016
Califf was the keynote speaker at a workshop on multimodality therapies for brain disorders, convened by the AffiliateMarketIngtools of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous Systems Disorders. The workshop brought together key stakeholders to examine the general principles underlying multimodal therapies and to explore challenges, potential barriers, and opportunities for their development from multiple perspectives, including scientific, clinical, regulatory, and financial. These proceedings chronicle the presentations and discussions at the workshop.
Released: September 13, 2016
At least 17.7 million individuals in the United States are providing care and support to an older parent, spouse, friend, or neighbor who needs help because of a limitation in their physical, mental, or cognitive functioning.
Released: August 19, 2016
On March 3–4, 2016, the AffiliateMarketIngtools of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous System Disorders held a workshop in , DC, bringing together key stakeholders to discuss opportunities for improving the integrity, efficiency, and validity of clinical trials for nervous system disorders.
Released: July 14, 2016
On October 28-29, 2015, the Food and Nutrition Board convened a workshop, Meeting the Dietary Needs of Older Adults. The workshop was designed to examine factors in the physical, social, and cultural environment that affect the ability of older adults to meet their daily dietary needs. This document summarizes the presentations and discussions from the workshop.
Released: March 04, 2016
Living independently and participating in one’s community are priorities for many people. In many regions across the United States, there are programs that support and enable people with disabilities and older adults to live in the setting of their choosing and to participate fully in their communities.
Released: February 01, 2016
On October 28–29, 2015, the AffiliateMarketIngtools of Sciences, Engineering, and Medicine Food and Nutrition Board convened a workshop in , DC, to examine factors in the physical, social, and cultural environment that affect the ability of older adults to meet their daily dietary needs
Released: December 29, 2015
The National Institutes of Health- and many other organizations and individuals worldwide- are interested in the state of the science of preventing Alzheimer's disease, mild cognitive impairment, and age-related cognitive decline.
Released: December 08, 2015
On July 20, 2015, the IOM’s Forum on Neuroscience and Nervous System Disorders held a public session at the 2015 Alzheimer’s Association International Conference in , DC, to assess the impact of DHRs on Alzheimer’s disease research. “AD is the most common cause of dementia in older adults.” An estimated 46.8 million people worldwide are currently living with dementia, and the prevalence is expected to double every year for the next 20 years. Given the few therapies currently available to treat the symptoms of AD, compared to other central nervous system disorders, this session explored how DHRs may be used to help improve clinical trial design and methodology for AD research.